Product Information

RIVASTIGMINE 1.5 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.1590 per EA under NDC 60687077701. Its NADAC has been published 130 times since Feb 28, 2024.

FDA first approved this application on Oct 31, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Rivastigmine Tartrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for RIVASTIGMINE 1.5 MG CAPSULE has been published 130 times since Feb 28, 2024, and over the history we have for it it has declined 24.7%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.